Comparison of C-reactive protein and procalcitonin as predictors of postoperative infectious complications after elective colorectal surgery

Dagmar Oberhofer, Josip Juras, Ana Marija Pavicić, Iva Rancić Zurić, Vlatko Rumenjak, Dagmar Oberhofer, Josip Juras, Ana Marija Pavicić, Iva Rancić Zurić, Vlatko Rumenjak

Abstract

Aim: To assess diagnostic value of perioperative procalcitonin (PCT) levels compared to C-reactive protein (CRP) levels in early detection of infectious complications following colorectal surgery.

Methods: This prospective observational study included 79 patients undergoing elective colorectal surgery. White blood cell count, CRP, and PCT were measured preoperatively and on postoperative days (POD) 1, 2, 3, 5, and patients were followed for postoperative complications. Diagnostic accuracy of CRP and PCT values on each day was analyzed by the receiver operating characteristics (ROC) curve, with infectious complications as an outcome measure. ROC curves with the largest area under the curve for each inflammatory marker were compared in order to define the marker with higher diagnostic accuracy.

Results: Twenty nine patients (36.7%) developed infectious complications. CRP and PCT concentrations increased in the early postoperative period, with a significant difference between patients with and without complications at all measured postoperative times. ROC curve analysis showed that CRP concentrations on POD 3 and PCT concentrations on POD 2 had similar predictive values for the development of infectious complications (area under the curve, 0.746 and 0.750, respectively) with the best cut-off values of 99.0 mg/L for CRP and 1.34 μg/L for PCT. Diagnostic accuracy of CRP and PCT was highest on POD 5, however the cut-off values were not considered clinically useful.

Conclusion: Serial postoperative PCT measurements do not offer an advantage over CRP measurements for prediction of infectious complications following colorectal surgery.

Figures

Figure 1
Figure 1
C-reactive protein (CRP) concentrations the day before surgery and on postoperative days (POD) 1-5 in patients with and without complications after colorectal surgery. The box represents 25th-75th percentiles and line within the box is the median value. P = 0.026 on POD 1, P = 0.002 on POD 2, P < 0.001 on PODs 3 and 5 (Mann-Whitney test). Asterisk indicates the group without complications n = 50; group with complications n = 29. Dagger indicates the group without complications n = 42; group with complications n = 27.
Figure 2
Figure 2
Perioperative procalcitonin (PCT) concentrations in patients with and without complications after colorectal surgery. The box represents 25th-75th percentiles and line within the box is the median value. P = 0.003 on postoperative day (POD) 1, P ≤ 0.001 on PODs 2-5 (Mann-Whitney test). Asterisk indicates the group without complications n = 49; group with complications n = 29. Dagger indicates the group without complications n = 37; group with complications n = 21.
Figure 3
Figure 3
Diagnostic accuracy of early postoperative (postoperative day [POD] 1-3) C-reactive protein (CRP) and procalcitonin (PCT) concentrations with regard to infectious complications expressed by the receiver operating characteristic (ROC) curves. Comparison of ROC curves with the largest area under the curve for each biomarker on PODs 1-3 shows similar diagnostic accuracy of CRP on POD 3 and PCT on POD 2 with the area under the curve of 0.746 and 0.750, respectively.

References

    1. Alves A, Panis Y, Mathieu P, Mantion G, Kwiatkowski F, Slim K. Postoperative mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective multicentric study. Arch Surg. 2005;140:278–83. doi: 10.1001/archsurg.140.3.278.
    1. Andreoni B, Chiappa A, Bertani E, Bellomi M, Orecchia R, Zampino M, et al. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients. World J Surg Oncol. 2007;5:73. doi: 10.1186/1477-7819-5-73.
    1. Hendry PO, Hausel J, Nygren J, Lassen K, Dejong CH, Ljungqvist O, et al. Determinants of outcome after colorectal resection within an enhanced recovery programme. Br J Surg. 2009;96:197–205. doi: 10.1002/bjs.6445.
    1. Ni Choileain, Redmond HP. Cell response to surgery. Arch Surg. 2006;141:1132–40. doi: 10.1001/archsurg.141.11.1132.
    1. Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta. 2005;351:17–29. doi: 10.1016/j.cccn.2004.08.018.
    1. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805–12.
    1. Lindberg M, Hole A, Johnsen H, Asberg A, Rydning A, Myrvold HE, et al. Reference intervals for procalcitonin and C-reactive protein after major abdominal surgery. Scand J Clin Lab Invest. 2002;62:189–94. doi: 10.1080/003655102317475443.
    1. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med. 1998;24:680–4. doi: 10.1007/s001340050644.
    1. Oberhofer D, Rumenjak V, Lazic J, Vucic N. Inflammatory indicators in patients after surgery of the large intestine. Acta Med Croatica. 2006;60:429–33.
    1. Welsch T, Muller SA, Ulrich A, Kischlat A, Hinz U, Kienle P, et al. C-reactive protein as early predictor for infectious postoperative complications in rectal surgery. Int J Colorectal Dis. 2007;22:1499–507. doi: 10.1007/s00384-007-0354-3.
    1. Matthiessen P, Henriksson M, Hallbook O, Grunditz E, Noren B, Arbman G. Increase of serum C-reactive protein is an early indicator of subsequent symptomatic anastomotic leakage after anterior resection. Colorectal Dis. 2008;10:75–80.
    1. Ortega-Deballon P, Radais F, Facy O, D’Athis P, Masson D, Charles PE, et al. C-reactive protein is an early predictor of septic complications after elective colorectal surgery. World J Surg. 2010;34:808–14. doi: 10.1007/s00268-009-0367-x.
    1. Korner H, Nielsen HJ, Soreide JA, Nedrebo BS, Soreide K, Knapp JC. Diagnostic accuracy of C-reactive protein for intraabdominal infections after colorectal resections. J Gastrointest Surg. 2009;13:1599–606. doi: 10.1007/s11605-009-0928-1.
    1. Woeste G, Müller C, Bechstein WO, Wullstein C. Increased serum levels of C-reactive protein precede anastomotic leakage in colorectal surgery. World J Surg. 2010;34:140–6. doi: 10.1007/s00268-009-0304-z.
    1. Dutta S, Fullarton GM, Forshaw MJ, Horgan PG, McMillan DC. Persistent elevation of C-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical site infectious complications. World J Surg. 2011;35:1017–25. doi: 10.1007/s00268-011-1002-1.
    1. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentration in patients with sepsis and infection. Lancet. 1993;341:515–8. doi: 10.1016/0140-6736(93)90277-N.
    1. Oczenski W, Fitzgerald RD, Schwarz S. Procalcitonin: a new parameter for the diagnosis of bacterial infection in the peri-operative period. Eur J Anaesthesiol. 1998;15:202–9.
    1. Reith HB, Mittelkotter U, Debus ES, Kussner C, Thiede A. Procalcitonin in early detection of postoperative complications. Dig Surg. 1998;15:260–5. doi: 10.1159/000018625.
    1. Rau B, Kruger CM, Schilling MK. Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis. Langenbecks Arch Surg. 2004;389:134–44. doi: 10.1007/s00423-004-0463-1.
    1. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34:1996–2003. doi: 10.1097/01.CCM.0000226413.54364.36.
    1. Hunziker S, Hugle T, Schuchardt K, Groeschl I, Schuetz P, Mueller B, et al. The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery. J Bone Joint Surg Am. 2010;92:138–48. doi: 10.2106/JBJS.H.01600.
    1. Falcoz PE, Laluc F, Toubin MM, Puyraveau M, Clement F, Mercier M, et al. Usefulness of procalcitonin in the early detection of infection after thoracic surgery. Eur J Cardiothorac Surg. 2005;27:1074–8. doi: 10.1016/j.ejcts.2005.02.022.
    1. Jebali MA, Hausfater P, Abbes Z, Aouni Z, Riou B, Ferjani M. Assessment of the accuracy of procalcitonin to diagnose postoperative infection after cardiac surgery. Anesthesiology. 2007;107:232–8. doi: 10.1097/.
    1. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection 1999. Am J Infect Control. 1999;27:97–132. doi: 10.1016/S0196-6553(99)70088-X.
    1. MacKay GJ, Molloy RG, O'Dwyer PJ. C-reactive protein as a predictor of postoperative infective complications following elective colorectal resection. Colorectal Dis. 2011;13:583–7. doi: 10.1111/j.1463-1318.2010.02236.x.
    1. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.
    1. Mustard RA, Jr, Bohnen JMA, Haseeb S, Kasina R. C-reactive protein levels predict postoperative septic complications. Arch Surg. 1987;122:69–73. doi: 10.1001/archsurg.1987.01400130075011.
    1. Povoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect. 2005;11:101–8. doi: 10.1111/j.1469-0691.2004.01044.x.
    1. Molter GP, Soltesz S, Kottke R, Wilhelm W, Biedler A, Silomon M. Procalcitonin plasma concentrations and systemic inflammatory response following different types of surgery. Anaesthesist. 2003;52:210–7. doi: 10.1007/s00101-003-0460-8.
    1. Mokart D, Merlin M, Sannini A, Brun JP, Delpero JR, Houvenaeghel G, et al. Procalcitonin, interleukin-6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth. 2005;94:767–73. doi: 10.1093/bja/aei143.

Source: PubMed

3
Se inscrever